News - Novartis
网页A legacy of blood cancer innovation. Media Release May 31, 2024. Latest analysis of Novartis NATALEE study shows Kisqali® reduces risk of cancer recurrence for early breast cancer patients with high-risk node-negative disease. All news. Novartis in Society Integrated Report 2023.
Novartis unveils new focused strategy, underpinned by eight …
网页2022年9月22日 · Focus on US and other priority geographies including China, Germany, Japan. These eight brands are underpinning growth across all key geographies, supporting Novartis aspiration to improve competitive positioning and organically build its US business to become a top-five player in the US by 2027.
Novartis announces new organizational structure to accelerate …
网页Basel, April 4, 2022 — Novartis today announced the introduction of a new organizational structure and operating model designed to support the company’s innovation, growth, and productivity ambitions as a focused medicines company in the coming decade.
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
网页2023年7月18日 · Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in shares as it prepares to spin off its Sandoz generics unit.
Novartis raises 2023 forecast, maps out Sandoz spin-off
网页FRANKFURT, July 18 (Reuters) - Novartis (NOVN.S) on Tuesday raised its full-year earnings forecast for the second time on strong drug sales and mapped out the planned separation and stock market...
Novartis’ Kisqali gets expanded FDA OK; Mene Pangalos joins …
网页3 天之前 · To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Today, a brief rundown of news from Novartis and GSK, as well as updates from Omega Funds, Serán ...
Novartis wins U.S. approval for targeted cancer drug combination
网页FRANKFURT, June 23 (Reuters) - A targeted oral drug combination by Novartis (NOVN.S) won U.S. approval for use in a wide range of advanced solid tumours that are driven by a certain genetic...
Novartis Kisqali® shows deepening benefit in new analysis, …
网页4 天之前 · Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. ... News; Novartis Kisqali® shows deepening benefit in ...
Novartis lifts 2023 earnings forecast for third time | Reuters
网页FRANKFURT, Oct 24 (Reuters) - Switzerland's Novartis (NOVN.S) on Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and higher-than-forecast prices for a multiple...
Coronavirus | Novartis
网页Find all coronavirus disease (COVID-19) news from Novartis regarding clinical trials, collaborations, aid contributions, and more.
跳至内容